(a) Specifications.
- (1) Each implant contains 2.1 milligrams (mg) deslorelin acetate.
- (2) [Reserved]
(b) Sponsors. See sponsor numbers in § 510.600(c) of this chapter as follows:
- (1) No. 051311 for use of product described in paragraph (a)(1) as in paragraph (c)(1) of this section.
- (2) [Reserved]
- (c) Conditions of use—(1) Horses and ponies—(i) Amount. One implant per mare subcutaneously in the neck.
- (ii) Indications for use. For inducing ovulation within 48 hours in estrous mares with an ovarian follicle greater than 30 millimeters (mm) in diameter.
- (iii) Limitations. Do not use in horses or ponies intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- (2) [Reserved]
[75 FR 81456, Dec. 28, 2010, as amended at 79 FR 18158, Apr. 1, 2014; 87 FR 17945, Mar. 29, 2022; 87 FR 58962, Sept. 29, 2022; 91 FR 41560, July 7, 2026]